An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
Active, not recruiting · NCT04130997 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis | Relapsing Multiple Sclerosis (RMS) | Active, not recruiting | Phase 3 | 2026-09-23 | NCT04130997 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| TG Therapeutics, Inc. | 16 |
86 results · Page 1 of 4
Research sites
Swipe the table sideways for more columns.